Premium
Crystal Structure of the Fab Fragment of an Anti‐CTLA‐4 Antibody, Ipilimumab, Used for Cancer Immunotherapy
Author(s) -
Lee Ju Yeon,
Lee Hyun Tae,
Lee Sang Hyung,
Lim Heejin,
Heo YongSeok
Publication year - 2019
Publication title -
bulletin of the korean chemical society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.237
H-Index - 59
ISSN - 1229-5949
DOI - 10.1002/bkcs.11712
Subject(s) - ipilimumab , cancer immunotherapy , antibody , immunotherapy , ctla 4 , fragment (logic) , cancer research , medicine , cancer , chemistry , immunology , immune system , t cell , computer science , programming language